Michael P Nghiem

Array ( [id] => 3931896 [patent_doc_number] => 05928923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Human short-chain dehydrogenase' [patent_app_type] => 1 [patent_app_number] => 9/019216 [patent_app_country] => US [patent_app_date] => 1998-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20935 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928923.pdf [firstpage_image] =>[orig_patent_app_number] => 019216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406876 [patent_doc_number] => 06309825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Analytical and therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/973318 [patent_app_country] => US [patent_app_date] => 1998-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7440 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309825.pdf [firstpage_image] =>[orig_patent_app_number] => 973318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416491 [patent_doc_number] => 06194207 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Methods for the selective expansion of lymphocytes by in vitro cultivation' [patent_app_type] => 1 [patent_app_number] => 9/016784 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 29 [patent_no_of_words] => 11763 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194207.pdf [firstpage_image] =>[orig_patent_app_number] => 016784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440906 [patent_doc_number] => 06335195 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation' [patent_app_type] => B1 [patent_app_number] => 09/012400 [patent_app_country] => US [patent_app_date] => 1998-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 13495 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335195.pdf [firstpage_image] =>[orig_patent_app_number] => 09012400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4335411 [patent_doc_number] => 06333171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'CD4 gene regulatory sequences specifically expressed in mature T cells' [patent_app_type] => 1 [patent_app_number] => 9/000127 [patent_app_country] => US [patent_app_date] => 1998-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8443 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333171.pdf [firstpage_image] =>[orig_patent_app_number] => 000127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328999 [patent_doc_number] => 06329517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Dermatomyositis-specific auto-antigen' [patent_app_type] => 1 [patent_app_number] => 8/913832 [patent_app_country] => US [patent_app_date] => 1998-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11399 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329517.pdf [firstpage_image] =>[orig_patent_app_number] => 913832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408711 [patent_doc_number] => 06232453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Gene encoding a polypeptide having pre-B cell growth-supporting ability' [patent_app_type] => 1 [patent_app_number] => 8/997252 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9192 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232453.pdf [firstpage_image] =>[orig_patent_app_number] => 997252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316746 [patent_doc_number] => 06242586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Mammalian cell surface antigens: related reagents' [patent_app_type] => 1 [patent_app_number] => 8/989362 [patent_app_country] => US [patent_app_date] => 1997-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15629 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242586.pdf [firstpage_image] =>[orig_patent_app_number] => 989362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294036 [patent_doc_number] => 06180600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'CD8 antagonists' [patent_app_type] => 1 [patent_app_number] => 8/875309 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9033 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180600.pdf [firstpage_image] =>[orig_patent_app_number] => 875309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560753 [patent_doc_number] => 06361939 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Isolated mammalian dendritic cell genes; related reagents' [patent_app_type] => B1 [patent_app_number] => 08/978289 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31995 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361939.pdf [firstpage_image] =>[orig_patent_app_number] => 08978289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023716 [patent_doc_number] => 05993815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)' [patent_app_type] => 1 [patent_app_number] => 8/966432 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15939 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993815.pdf [firstpage_image] =>[orig_patent_app_number] => 966432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004791 [patent_doc_number] => 05888742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Human phospholipid binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/958820 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21676 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888742.pdf [firstpage_image] =>[orig_patent_app_number] => 958820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180017 [patent_doc_number] => 06020161 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'PIGR-1, a member of immunoglobulin gene superfamily' [patent_app_type] => 1 [patent_app_number] => 8/955937 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10963 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020161.pdf [firstpage_image] =>[orig_patent_app_number] => 955937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196596 [patent_doc_number] => 06013495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Methods of use for integrin B.sub.1C cell growth inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/951200 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 11125 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013495.pdf [firstpage_image] =>[orig_patent_app_number] => 951200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103607 [patent_doc_number] => 06056951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Method of reducing the chance of attack of cells in a body by the cellular immune system' [patent_app_type] => 1 [patent_app_number] => 8/946606 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6302 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/056/06056951.pdf [firstpage_image] =>[orig_patent_app_number] => 946606 [rel_patent_id] =>[rel_patent_doc_number] =>)